Applied Therapeutics, Inc.
APLT
$0.4101
-$0.0309-7.01%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2,466.84% | 103.45% | -122.77% | 11.07% | -43.25% |
| Total Depreciation and Amortization | -14.75% | 1.67% | 1,900.00% | -94.92% | 1.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 302.74% | -131.50% | 248.24% | -35.45% | 94.61% |
| Change in Net Operating Assets | 162.03% | -323.39% | -166.76% | 191.86% | 11.21% |
| Cash from Operations | -3.25% | -19.48% | -11.21% | -15.48% | 10.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 33.12% | 0.00% | -51.96% |
| Issuance of Common Stock | -- | -- | 287.18% | 75.62% | -38.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | 100.00% | -101.46% | 292.23% | 77.74% | -43.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.94% | -125.15% | 676.35% | 575.77% | -85.50% |
